Home › Glycogen Storage Disease Type II › Missouri
Glycogen Storage Disease Type II clinical trials in Missouri
6 studies for Glycogen Storage Disease Type II are looking for participants at sites in Missouri.
Cities in Missouri
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT07354724Pompe Disease Registry Protocol
- University of Missouri Health System Department of Genetics- Site Number : 840031, Columbia
- Washington University- Site Number : 840100, St Louis
RecruitingObservational study
All ages · All sexes · Updated Jun 23, 2026 · NCT00231400Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
- Washington University in St. Louis, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT07123155Pompe Pregnancy Sub-Registry
- Washington University- Site Number : 150612, St Louis
RecruitingObservational study
All ages · Women · Updated Apr 16, 2026 · NCT00567073Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
- NextGen Precision Health Building, Clinical and Translational Science Unit, Columbia
Recruiting
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT07478172A Global Prospective Observational Registry of Patients With Pompe Disease
- Washington University School of Medicine, St Louis
RecruitingObservational study
All ages · All sexes · Updated Mar 10, 2026 · NCT06121011From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.